BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, May 8, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 5, 2010
View Archived Issues
Further data from IMPACT trials of C1-INH in hereditary angioedema reported
Read More
Some clinical benefit of tremelimumab in phase II metastatic gastric/esophageal adenocarcinoma trial
Read More
Ixabepilone therapy linked to tumor regression in phase II metastatic renal cell carcinoma trial
Read More
Merck & Co. reports new potent and selective GPR109A agonist
Read More
GlaxoSmithKline claims novel antibacterial agents
Read More
NicOx describes novel nitric oxide-releasing steroids
Read More
Merck & Co. and NicOx claim new angiotensin II receptor antagonists
Read More
Myriad launched Prolaris to predict prostate cancer recurrence
Read More
Bristol-Myers highlights pipeline and biopharmaceutical strategy
Read More
SpePharm acquires rights to Savene and partners with Paladin
Read More
Kinex begins phase II trial of KX2-391 in bone-metastatic CRPC
Read More
Vaxart raises funds for development avian influenza vaccine
Read More
U.K. JCVI recommends Intercell's Japanese encephalitis vaccine Ixiaro
Read More
BioVex initiates phase I trial of genital herpes vaccine ImmunoVEX-HSV2
Read More
Biomoda and Amigenics announce collaboration
Read More
Stemgent invests in new biotechnology company Ubiquigent
Read More
DSMB supports continuation phase II Doxil trial in platinum-resistant ovarian cancer
Read More
Vertex identifies novel PKC-theta inhibitors
Read More
Foamix and Therapeutics collaborate to develop inflammatory skin disease therapies
Read More
Cell Therapeutics' phase III Opaxio trial in ovarian cancer to continue
Read More
Mount Sinai School of Medicine and Medisyn discover new potential Alzheimer's disease therapeutics
Read More
Rexahn submits protocol of phase IIb Zoraxel trial in erectile dysfunction to FDA
Read More
NeoStem and University of Michigan enter into sponsored research agreement
Read More
Merck & Co. presents update on late-stage pipeline following merger with Schering-Plough
Read More
Preliminary clinical data support the use of vaginal diazepam
Read More